Your browser doesn't support javascript.
loading
Transglutaminase 3 suppresses proliferation and cisplatin resistance of cervical cancer cells by inactivation of the PI3K/AKT pathway.
Chen, Ruipu; Fang, Tingyu; Liu, Na; Shi, Xuejiao; Wang, Junsen; Yu, Huaping.
Affiliation
  • Chen R; International Department of Obstetrics, Fokind Hospital Affiliated to Tibet University, Lhasa, 850099, Tibet, China. syycrp2023@163.com.
  • Fang T; Department of Obstetrics, Fokind Hospital Affiliated to Tibet University, Lhasa, 850099, Tibet, China.
  • Liu N; International Department of Obstetrics, Fokind Hospital Affiliated to Tibet University, Lhasa, 850099, Tibet, China.
  • Shi X; Department of Nursing, Fokind Hospital Affiliated to Tibet University, Lhasa, 850099, Tibet, China.
  • Wang J; Department of Operating, Fokind Hospital Affiliated to Tibet University, Lhasa, 850099, Tibet, China.
  • Yu H; International Department of Obstetrics, Fokind Hospital Affiliated to Tibet University, Lhasa, 850099, Tibet, China.
Naunyn Schmiedebergs Arch Pharmacol ; 397(4): 2269-2280, 2024 04.
Article in En | MEDLINE | ID: mdl-37812238
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Peptide Fragments / Uterine Cervical Neoplasms / Cisplatin / Receptors, Platelet-Derived Growth Factor Limits: Female / Humans Language: En Journal: Naunyn Schmiedebergs Arch Pharmacol Year: 2024 Document type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Peptide Fragments / Uterine Cervical Neoplasms / Cisplatin / Receptors, Platelet-Derived Growth Factor Limits: Female / Humans Language: En Journal: Naunyn Schmiedebergs Arch Pharmacol Year: 2024 Document type: Article